Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, hydrochloride (1:1), (1S,2R)-, 99%, 1g

2-Pyridineethanol>98.0%(GC)(T)25mL

(S)-1-(tert-Butoxycarbonyl)indoline-2-carboxylic acid, 97.0%, 25g

(S)-2-((tert-Butoxycarbonyl)amino)-2-(4-fluorophenyl)acetic acid, 95.0%, 250mg

5-Chloropyridazin-4-ol, 95.0%, 1g

3-Hydroxy-2-pyrrolidinone, 95.0%, 5g

3-(2,4-Difluorophenyl)-3-oxo-propionic acid ethyl ester, 95.0%, 2g

(R)-2-Phenyl-2-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)acetonitrile, 95%, 10g

3-(6-Aminopyridin-3-yl)benzaldehyde, 95%, 500mg

TRANS-2-(TRIFLUOROMETHYL)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 1g

(R)-4-PHENYL-2-(QUINOLIN-2-YL)-4,5-DIHYDROOXAZOLE, 97%, 5g

4-Amino-furazan-3-carboxylic acid ethyl ester, 98.0%, 1g

3-Bromocyclopentane-1-carboxylic acid, 97%, 250mg